The Centers for Medicare & Medicaid Services announced today that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration to include IRFs in Texas and California. The ...
CMS has announced results of demonstration programs for large physician practices, small and solo physician practices and hospitals, in which the agency pays providers for meeting certain quality ...
After widespread criticism from healthcare providers, drug companies, and lawmakers, CMS has announced that it will not go forward with its proposed Medicare Part B payment program. The experimental ...
The "Pathways to Coverage" demonstration was borne out of the Health Adult Opportunity guidance released by CMS earlier this year. The Centers for Medicare & Medicaid Services (CMS) announced that ...
The proposed integrity audit on inpatient rehabilitation facilities in four states during the public health emergency raises a number of concerns for hospitals. Stakeholders are asking the federal ...
Our Health Care Group reviews a new five-year CMS demonstration project requiring ambulatory surgical centers (ASCs) in 10 states to obtain approval before performing certain procedures. The ...
CBO’s Report on Medicare’s Demonstration Projects: What the Numbers Really Mean, and Why They Matter
The following is reprinted with permission from Oliver Wyman. Several weeks ago, the Congressional Budget Office released an analysis of 10 CMS demonstration projects. The headline for CBO and much of ...
The Centers for Medicare and Medicaid Services is asking organizations to provide information about artificial intelligence technologies for use in health care outcomes and service delivery as it ...
On June 27, 2023, CMS hosted a Special Open Door Forum regarding its Review Choice Demonstration program for Inpatient Rehabilitation Facility Services (IRFs). CMS has stated that the Medicare IRF ...
Options for Medicare and Medicaid Dual Coverage People who are eligible for both Medicare and Medicaid benefits are referred to as dual eligible. A person may have partial or full dual eligibility.
The decision on how to cover an expensive and controversial new Alzheimer’s drug could be settled by letting Medicare run its own trial to study payment and treatment implications. Aduhelm, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback